AV

Aviva plc is older than the Bank of England's bond market, older than the concept of modern actuarial science, and older than most of the countries in which it operates. Founded in 1696 as the Hand in Hand Fire and Life Insurance Society, the company has outlived empires, two world wars, the collapse of the UK building society sector, and at least three major insurance industry consolidation waves. That longevity is not decorative. It is the clearest signal that Aviva's structural role is not to define markets but to survive them.

The central analytical question in April 2026 is whether Aviva, after a decade of portfolio surgery under three successive CEOs, has finally settled into a stable strategic identity. Under Dame Amanda Blanc, the company has divested its French, Italian, Polish, Singaporean, and Vietnamese businesses, reduced its balance sheet complexity, and refocused on three core geographies: the United Kingdom, Ireland, and Canada. In 2025, it completed the acquisition of Direct Line Group, a transformative transaction that makes Aviva the largest personal lines insurer in the United Kingdom by gross written premium. Revenue jumped from £40.9 billion in 2024 to £58.5 billion in 2025. Market capitalization sits near £19 billion, with shares at 627p inside a 52-week range of 504p to 701p.

Here is the observation that does not appear in any standard data provider: Aviva's competitive power does not come from being the best at any single product line. It comes from being the only UK-listed composite insurer that still combines life, pensions, general insurance, health, and wealth management at scale under one regulated roof. In a sector where Legal and General exited general insurance, Prudential spun off its UK business, and Standard Life merged away its insurance operations, Aviva's decision to remain composite is now the structural position. That is not a moat. It is a balancing act made possible by the absence of competition for the same role.